This Proactive article explains their lead drug candidate AD214 pretty well
**promotion blocked**.au/companies/news/976475/the-smart-money-in-medicine-combatting-fibrosis-976475.html
Also a couple of other irons in the fire, a CAR T tie up and an imaging agent tie up.
All built upon patented platform for drug discovery based upon shark antibodies (smaller than human antibodies).
About $10m in bank at last quarterly.
There's a bit of a wait until Phase II starts next year but busy doing other studies in the meantime to test an inhaled version of AD214.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $3.704K | 1.851M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 19990238 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 6130560 | 15 |
View Market Depth
| Last trade - 14.58pm 23/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |